AstraZeneca and Bristol Myers Squibb in Merger Talks to Create Nearly $400 Billion Pharma Giant
Key Questions
What is the goal of the PMNCH global campaign?
PMNCH launched the campaign to secure financing for women's, children's, and adolescents' health amid sharp aid reductions. It addresses the 23.1% drop in official development assistance recorded in 2025.
What data illustrates the scale of the global health financing crisis?
Official development assistance for health fell 23.1% in 2025, with 89% of partners reporting cuts. This steep decline is the largest on record and strains health systems worldwide.
What solutions does the campaign promote to address aid dependency?
The initiative emphasizes domestic resource mobilization and reducing debt burdens that crowd out health budgets. It calls for redesigned global health governance to sustain essential services.
AstraZeneca and Bristol Myers Squibb are in merger talks to create a combined entity worth nearly $400 billion. The deal would reshape pharma consolidation, driven by patent cliff pressures and oncology overlap. Regulatory hurdles and UK 'brain drain' implications are key angles. Talks are ongoing, no final agreement.